Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | USP2 | O75604 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22493532 | 1.00 | TSHR (0.48) | TSHRALDH1A1USP2MAPTCYP3A4 | |
| SCHEMBL22493533 | 1.00 | TSHR (0.48) | TSHRALDH1A1USP2MAPTCYP3A4 | |
| SCHEMBL5575846 | 1.00 | TSHR (0.48) | TSHRALDH1A1USP2MAPTCYP3A4 | |
| SCHEMBL19639475 | 1.00 | TSHR (0.48) | TSHRALDH1A1USP2MAPTCYP3A4 | |
| SCHEMBL14743385 | 1.00 | TSHR (0.48) | TSHRALDH1A1USP2MAPTCYP3A4 | |
| SCHEMBL22493527 | 1.00 | TSHR (0.48) | TSHRALDH1A1USP2MAPTCYP3A4 | |
| SCHEMBL8425055 | 1.00 | TSHR (0.48) | TSHRALDH1A1USP2MAPTCYP3A4 | |
| SCHEMBL313009 | 0.98 | — | — | |
| SCHEMBL22493549 | 0.90 | — | — | |
| SCHEMBL30319221 | 0.87 | TSHR (0.41) | TSHRALDH1A1USP2MAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111348-B2 | Method for treating surface of resin material layer and resin material | MITSUBISHI HEAVY INDUSTRIES, LTD. (JP) | 2021-09-07 | — | — | US | disclosed |
| EP-3450488-B1 | METHOD FOR TREATING SURFACE OF RESIN MATERIAL LAYER AND RESIN MATERIAL | MITSUBISHI HEAVY IND LTD (JP) | 2021-03-24 | — | — | EP | disclosed |
| US-20200317876-A1 | METHOD FOR TREATING SURFACE OF RESIN MATERIAL LAYER AND RESIN MATERIAL | MITSUBISHI HEAVY INDUSTRIES, LTD. (JP) | 2020-10-08 | — | — | US | disclosed |
| US-10590331-B2 | Mixed dimers from alpha-olefin sulfonic acids | STEPAN COMPANY (US) | 2020-03-17 | — | — | US | disclosed |
| EP-2958148-B1 | ELECTRONIC DEVICE USING ORGANIC THIN FILM, AND ELECTRONIC APPARATUS CONTAINING SAME | JAPAN SCIENCE & TECH AGENCY (JP) | 2019-10-02 | — | — | EP | disclosed |
| EP-3331963-B1 | MIXED DIMERS FROM ALPHA-OLEFIN SULFONIC ACIDS | STEPAN CO (US) | 2019-07-10 | — | — | EP | disclosed |
| US-20180223173-A1 | MIXED DIMERS FROM ALPHA-OLEFIN SULFONIC ACIDS | STEPAN COMPANY | 2018-08-09 | — | — | US | disclosed |
| US-9825232-B2 | Electronic device using organic thin film, and electronic apparatus containing the same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20160005974-A1 | ELECTRONIC DEVICE USING ORGANIC THIN FILM, AND ELECTRONIC APPARATUS CONTAINING THE SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2016-01-07 | — | — | US | disclosed |
| EP-2958148-A1 | ELECTRONIC DEVICE USING ORGANIC THIN FILM, AND ELECTRONIC APPARATUS CONTAINING SAME | Japan Science And Technology Agency (JP) | 2015-12-23 | — | — | EP | disclosed |
| CN-1898279-A | Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof | EXXONMOBIL RES & ENG CO (US) | 2007-01-17 | — | — | CN | disclosed |
| US-5686021-A | Liquid crystal display device, methods of producing and driving the liquid crystal display device, and liquid crystal composition | IDEMITSU KOSAN CO., LTD. (JP) | 1997-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160005974-A1 | ELECTRONIC DEVICE USING ORGANIC THIN FILM, AND ELECTRONIC APPARATUS CONTAINING THE SAME | EED, EFNA1, ESYT2 | TSHR 2538/4885ALDH1A1 3446/4885USP2 2262/4885 |
| US-20180223173-A1 | MIXED DIMERS FROM ALPHA-OLEFIN SULFONIC ACIDS | DEGS1, FADS1, FADS2 | TSHR 4652/4885ALDH1A1 2328/4885USP2 2162/4885 |
| US-10590331-B2 | Mixed dimers from alpha-olefin sulfonic acids | DEGS1, FADS1, FADS2 | TSHR 4652/4885ALDH1A1 2328/4885USP2 2162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.